Ilsung Pharm (003120) — Cash Flow Quality Index
Ilsung Pharm (003120) has a Cash Flow Quality Index of -0.91x as of December 2025. Operating cash flow of ₩-3.10 Billion is below net income of ₩3.41 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 003120 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Ilsung Pharm Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Ilsung Pharm across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Ilsung Pharm (003120) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Ilsung Pharm (2013–2025)
Year-by-year earnings quality comparison for Ilsung Pharm. For live market cap and the full company financial profile, see Ilsung Pharm (003120) total market value.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.33x | ₩3.88 Billion | ₩1.17 Billion | ▲ +1124.3% |
| 2024 | -0.33x | ₩-4.26 Billion | ₩13.09 Billion | ▲ +12.2% |
| 2022 | -0.37x | ₩-38.97 Billion | ₩105.24 Billion | ▼ -176.6% |
| 2020 | 0.48x | ₩1.56 Billion | ₩3.22 Billion | ▼ -26.0% |
| 2019 | 0.65x | ₩4.39 Billion | ₩6.72 Billion | ▼ -87.3% |
| 2018 | 5.12x | ₩15.09 Billion | ₩2.95 Billion | ▲ +32.6% |
| 2017 | 3.86x | ₩10.16 Billion | ₩2.63 Billion | ▲ +137.6% |
| 2016 | -10.28x | ₩-31.01 Billion | ₩3.02 Billion | ▼ -16919.6% |
| 2015 | 0.06x | ₩6.04 Billion | ₩98.85 Billion | ▼ -94.1% |
| 2014 | 1.04x | ₩4.19 Billion | ₩4.03 Billion | ▲ +63.2% |
| 2013 | 0.64x | ₩5.06 Billion | ₩7.96 Billion | — |